134 related articles for article (PubMed ID: 15359999)
1. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.
Kuzu I; Beksac M; Arat M; Celebi H; Elhan AH; Erekul S
Leuk Lymphoma; 2004 Jun; 45(6):1185-90. PubMed ID: 15359999
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow microvessel density and its prognostic significance in AML.
Rabitsch W; Sperr WR; Lechner K; Chott A; Prinz E; Valent P; Kalhs P
Leuk Lymphoma; 2004 Jul; 45(7):1369-73. PubMed ID: 15359635
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Kim CK; Han DH; Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Lee KT; Won JH; Hong DS; Kim HK
Leuk Res; 2016 Nov; 50():21-28. PubMed ID: 27639703
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
Korkolopoulou P; Viniou N; Kavantzas N; Patsouris E; Thymara I; Pavlopoulos PM; Terpos E; Stamatopoulos K; Plata E; Anargyrou K; Androulaki A; Davaris P; Yataganas X
Leukemia; 2003 Jan; 17(1):89-97. PubMed ID: 12529665
[TBL] [Abstract][Full Text] [Related]
5. Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study.
Todorovic M; Radisavljevic Z; Balint B; Andjelic B; Todorovic V; Jovanovic MP; Mihaljevic B
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):488-93. PubMed ID: 22417860
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
[TBL] [Abstract][Full Text] [Related]
7. A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations.
Korkolopoulou P; Gribabis DA; Kavantzas N; Angelopoulou MK; Siakantaris MP; Patsouris E; Androulaki A; Thymara I; Kokoris SI; Kyrtsonis MC; Kittas C; Pangalis GA
Br J Haematol; 2003 Sep; 122(6):900-10. PubMed ID: 12956759
[TBL] [Abstract][Full Text] [Related]
8. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Padró T; Ruiz S; Bieker R; Bürger H; Steins M; Kienast J; Büchner T; Berdel WE; Mesters RM
Blood; 2000 Apr; 95(8):2637-44. PubMed ID: 10753845
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
10. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
[TBL] [Abstract][Full Text] [Related]
11. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
Zhang JQ; Wang JK; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
[TBL] [Abstract][Full Text] [Related]
13. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
AbdElAal Asmaa A; Afify RA; Zaher AE; ElGammal MM; Atef AM
Hematology; 2015 Oct; 20(9):504-10. PubMed ID: 25885121
[TBL] [Abstract][Full Text] [Related]
14. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
15. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.
Des Guetz G; Uzzan B; Nicolas P; Cucherat M; Morere JF; Benamouzig R; Breau JL; Perret GY
Br J Cancer; 2006 Jun; 94(12):1823-32. PubMed ID: 16773076
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Contrast-Enhanced Ultrasound and Microvessel Density via CD31 and CD34 in a rabbit VX2 lung peripheral tumor model.
Xing J; He W; Ding YW; Li Y; Li YD
Med Ultrason; 2018 Feb; 1(1):37-42. PubMed ID: 29400366
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
